Vanguard Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,537,011
Closed -$123M 4196
2019
Q3
$123M Sell
6,537,011
-124,124
-2% -$2.34M ﹤0.01% 1602
2019
Q2
$78.4M Buy
6,661,135
+111,886
+2% +$1.32M ﹤0.01% 1880
2019
Q1
$89.4M Buy
6,549,249
+1,284,019
+24% +$17.5M ﹤0.01% 1807
2018
Q4
$54M Buy
5,265,230
+111,021
+2% +$1.14M ﹤0.01% 1985
2018
Q3
$85.8M Buy
5,154,209
+115,375
+2% +$1.92M ﹤0.01% 1878
2018
Q2
$79.6M Sell
5,038,834
-240,441
-5% -$3.8M ﹤0.01% 1885
2018
Q1
$67M Sell
5,279,275
-79,961
-1% -$1.02M ﹤0.01% 1917
2017
Q4
$61.4M Buy
5,359,236
+333,659
+7% +$3.82M ﹤0.01% 1960
2017
Q3
$61.6M Buy
5,025,577
+1,399,004
+39% +$17.1M ﹤0.01% 1943
2017
Q2
$41.5M Buy
3,626,573
+187,871
+5% +$2.15M ﹤0.01% 2104
2017
Q1
$71.5M Buy
3,438,702
+194,185
+6% +$4.04M ﹤0.01% 1825
2016
Q4
$67.5M Buy
3,244,517
+91,369
+3% +$1.9M ﹤0.01% 1832
2016
Q3
$103M Buy
3,153,148
+60,630
+2% +$1.99M 0.01% 1539
2016
Q2
$77.2M Buy
3,092,518
+893,334
+41% +$22.3M ﹤0.01% 1684
2016
Q1
$53.9M Buy
2,199,184
+49,460
+2% +$1.21M ﹤0.01% 1833
2015
Q4
$71M Buy
2,149,724
+304,556
+17% +$10.1M ﹤0.01% 1705
2015
Q3
$60.4M Buy
1,845,168
+617,685
+50% +$20.2M ﹤0.01% 1763
2015
Q2
$65M Buy
1,227,483
+634,874
+107% +$33.6M ﹤0.01% 1792
2015
Q1
$17.1M Buy
592,609
+358,879
+154% +$10.4M ﹤0.01% 2391
2014
Q4
$6.8M Buy
233,730
+88,207
+61% +$2.57M ﹤0.01% 2732
2014
Q3
$1.85M Buy
145,523
+63,384
+77% +$804K ﹤0.01% 3302
2014
Q2
$1.65M Buy
+82,139
New +$1.65M ﹤0.01% 3336